CIK: 0001602263
Total reported value
$379.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Avexis INC | Stock-Other | 30.74% | — | — | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 15.15% | -4.69% | — | |
| 3 | ASND | Ascendis Pharma A/S | Stock-Other | 10.94% | -8.61% | EXIT | |
| 4 | EWTX | Edgewise Therapeutics, Inc. | Stock-Other | 7.92% | — | — | |
| 5 | ✓ | DBV Technologies | Stock-Other | 7.56% | — | — | |
| 6 | RARXEUR | Ra Pharmaceuticals INC | Stock-Other | 5.76% | -6.10% | EXIT | |
| 7 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 5.50% | -3.14% | EXIT | |
| 8 | ARGX | Argenx Se - Adr | Stock-Healthcare | 5.44% | — | — | |
| 9 | ✓ | Axovant Sciences LTD | Stock-Other | 2.79% | — | -29.77% | |
| 10 | XLRN | Acceleron Pharma INC | Stock-Other | 1.90% | — | — | |
| 11 | CTMX | Cytomx Therapeutics INC | Stock-Other | 1.79% | — | — | |
| 12 | ✓ | ARCA biopharma Inc | Stock-Other | 1.03% | — | — | |
| 13 | ✓ | Stock-Other | 0.78% | — | +15.37% | ||
| 14 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 0.65% | +0.05% | — | |
| 15 | ✓ | Lipocine INC New | Stock-Other | 0.62% | — | -7.87% | |
| 16 | ✓ | Ocera Therapeutics INC | Stock-Other | 0.56% | — | — | |
| 17 | ✓ | Obseva SA | Stock-Other | 0.51% | -5.57% | — | |
| 18 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 0.28% | +1.16% | NEW | |
| 19 | SRRAEUR | Sierra Oncology INC | Stock-Other | 0.06% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | +1.6% | +21.57% | Add |
| 2 | EWTX | Edgewise Therapeutics, Inc. | +0.7% | — | Unchanged |
| 3 | XLRN | Acceleron Pharma INC | +0.2% | — | Unchanged |
| 4 | ✓ | Axovant Sciences LTD | +0.2% | -29.77% | Trim |
| 5 | SRRAEUR | Sierra Oncology INC | 0% | — | Unchanged |
| 6 | 4XC1 | Kalvista Pharmaceuticals INC | 0% | — | Unchanged |
| 7 | ADVMCHF | Adverum Biotechnologies INC | 0% | — | Unchanged |
| 8 | ✓ | Lipocine INC New | -0.1% | -7.87% | Trim |
| 9 | ✓ | DBV Technologies | -0.1% | — | Unchanged |
| 10 | ✓ | Ocera Therapeutics INC | -0.1% | — | Unchanged |
| 11 | ✓ | ARCA biopharma Inc | -0.1% | — | Unchanged |
| 12 | CTMX | Cytomx Therapeutics INC | -0.3% | — | Unchanged |
| 13 | RARXEUR | Ra Pharmaceuticals INC | -0.6% | +6.17% | Add |
| 14 | ✓ | -0.9% | +15.37% | Add | |
| 15 | ✓ | Avexis INC | -1.5% | — | Unchanged |
| 16 | BCRX | Biocryst Pharmaceuticals INC | -15.4% | -59.23% | Trim |
| 17 | BHVN | Biohaven Ltd. | — | NEW | New buy |
| 18 | ARGX | Argenx Se - Adr | — | NEW | New buy |
| 19 | BOLDEUR | Audentes Therapeutics INC | — | EXIT | Sold out |
| 20 | CHRS | Coherus Oncology INC | — | EXIT | Sold out |
| 21 | STMLEUR | Stemline Therapeutics INC | — | EXIT | Sold out |
| 22 | ✓ | Obseva SA | — | NEW | New buy |
| 23 | ✓ | Alcobra Ltd | — | EXIT | Sold out |